List of Knopp Biosciences patents

Patents where

Current Assignee

Name

Knopp Biosciences

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9849116 Compositions and methods of using (R)-pramipexole	Patent 9849116 was granted and assigned to Knopp Biosciences on December, 2017 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	9849116	December 26, 2017
‌ US Patent 9956206 Compositions and methods for treating amyotrophic lateral sclerosis in responders	Patent 9956206 was granted and assigned to Knopp Biosciences on May, 2018 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	9956206	May 1, 2018
‌ US Patent 9662313 Compositions and methods for treating amyotrophic lateral sclerosis in responders	Patent 9662313 was granted and assigned to Knopp Biosciences on May, 2017 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	9662313	May 30, 2017
‌ US Patent 9650376 Imidazo(4,5-	Patent 9650376 was granted and assigned to Knopp Biosciences on May, 2017 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	9650376	May 16, 2017
‌ US Patent 10179774 Synthesis of chirally purified substituted benzothiazole diamines	Patent 10179774 was granted and assigned to Knopp Biosciences on January, 2019 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	10179774	January 15, 2019
‌ US Patent 9481653 Benzoimidazol-1,2-yl amides as Kv7 channel activators	Patent 9481653 was granted and assigned to Knopp Biosciences on November, 2016 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	9481653	November 1, 2016
‌ US Patent 9512096 Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds	Patent 9512096 was granted and assigned to Knopp Biosciences on December, 2016 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	9512096	December 6, 2016
‌ US Patent 10208003 Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds	Patent 10208003 was granted and assigned to Knopp Biosciences on February, 2019 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	10208003	February 19, 2019
‌ US Patent 11026928 Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils	Patent 11026928 was granted and assigned to Knopp Biosciences on June, 2021 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	11026928	June 8, 2021
‌ US Patent 10383857 Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils	Patent 10383857 was granted and assigned to Knopp Biosciences on August, 2019 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	10383857	August 20, 2019
‌ US Patent 9763918 Compositions and methods for treating chronic urticaria	Patent 9763918 was granted and assigned to Knopp Biosciences on September, 2017 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	9763918	September 19, 2017
‌ US Patent 10195183 Compositions and methods for treating chronic urticaria	Patent 10195183 was granted and assigned to Knopp Biosciences on February, 2019 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	10195183	February 5, 2019
‌ US Patent 9642840 Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders	Patent 9642840 was granted and assigned to Knopp Biosciences on May, 2017 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	9642840	May 9, 2017
‌ US Patent 9468630 Compositions and methods for treating conditions related to increased eosinophils	Patent 9468630 was granted and assigned to Knopp Biosciences on October, 2016 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	9468630	October 18, 2016
‌ US Patent 10028940 Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders	Patent 10028940 was granted and assigned to Knopp Biosciences on July, 2018 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	10028940	July 24, 2018
‌ US Patent 10383856 Compositions and methods for treating conditions related to increased eosinophils	Patent 10383856 was granted and assigned to Knopp Biosciences on August, 2019 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	10383856	August 20, 2019
‌ US Patent 10980783 Compositions and methods for treating conditions related to increased eosinophils	Patent 10980783 was granted and assigned to Knopp Biosciences on April, 2021 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	10980783	April 20, 2021
‌ US Patent 10385025 Benzoimidazol-1,2-yl amides as Kv7 channel activators	Patent 10385025 was granted and assigned to Knopp Biosciences on August, 2019 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	10385025	August 20, 2019
‌ US Patent 9914708 Benzoimidazol-1,2-yl amides as Kv7 channel activators	Patent 9914708 was granted and assigned to Knopp Biosciences on March, 2018 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	9914708	March 13, 2018
‌ US Patent 10106536 Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators	Patent 10106536 was granted and assigned to Knopp Biosciences on October, 2018 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	10106536	October 23, 2018
‌ US Patent 11261162 KV7 channel activators compositions and methods of use	Patent 11261162 was granted and assigned to Knopp Biosciences on March, 2022 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	11261162	March 1, 2022
‌ US Patent 10906877 Benzoimidazol-1,2-yl amides as Kv7 channel activators	Patent 10906877 was granted and assigned to Knopp Biosciences on February, 2021 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	10906877	February 2, 2021
‌ US Patent 10851067 Kv7 channel activators compositions and methods of use	Patent 10851067 was granted and assigned to Knopp Biosciences on December, 2020 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	10851067	December 1, 2020
‌ US Patent 10526328 Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activators	Patent 10526328 was granted and assigned to Knopp Biosciences on January, 2020 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	10526328	January 7, 2020
‌ US Patent 10456381 Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders	Patent 10456381 was granted and assigned to Knopp Biosciences on October, 2019 by the United States Patent and Trademark Office.	Knopp Biosciences	Knopp Biosciences	United States Patent and Trademark Office	10456381	October 29, 2019

Results per page:

26 results

0 selected

26 results

0 selected